Table 1.
Blood Test Comparison Pre- and Postimplementation
| Preimplementation Tests(June 2019 to Feb 2020) | Postimplementation tests(March to Oct 2020) | Reduction Mean/bedday |
P * | |||
|---|---|---|---|---|---|---|
| Absolute tests | Mean/bedday | Absolute tests | Mean/bedday | |||
| FBC | 4,020 | 0.95 | 2,780 | 0.65 | 32% | p < 0.0001 |
| EUC | 4,654 | 1.10 | 3,643 | 0.85 | 23% | p < 0.0001 |
| LFT | 3,822 | 0.91 | 1,853 | 0.43 | 52% | p < 0.0001 |
| CMP | 3,801 | 0.90 | 2,368 | 0.55 | 37% | p < 0.0001 |
*Poisson regression based on mean blood tests/bedday.
CMP, calcium magnesium phosphate; EUC, electrolytes, urea, creatinine.; FBC, full blood count; LFT, Liver Function Tests.